[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Sheng Liu\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100484989",false,"NCT05595226","Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease","TEEMR","Inclusion Criteria:\n\n* Diagnosed with chronic primary degenerative mitral regurgitation by the preoperative echocardiogram.\n* Informed consent was obtained\n\nExclusion Criteria:\n\n* Re-operation of mitral regurgitation\n* Concurrent surgical plan for congenital heart disease, coronary artery bypass grafting, aortic valve surgery, radiofrequency ablation of atrial fibrillation and other cardiac surgeries.\n* Mitral valve replacement\n* Unable to undergo TEE","ALL","18 Years","80 Years",{"count":19,"type":20},338,"ESTIMATED","INTERVENTIONAL",[23],"NA","The aim of this randomized controlled trial to investigate the effects of Real-time 3D transesophageal echocardiography (RT3D-TEE)-guided mitral valve repair on surgical failure and 1-year reoccurrence of mitral valve regurgitation in patients with degenerative mitral value disease.",[26],"Degenerative Mitral Valve Disease","RECRUITING","2022-10-26",{"date":30,"type":31},"2022-10-28","ACTUAL",{"date":33,"type":31},"2021-12-31",{"date":35,"type":20},"2026-12-31",{"name":37,"class":38},"Sheng Liu","OTHER",""]